News Sentiment

SNGX sentiment intelligence

Soligenix Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 44 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.36 Week of 17 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 35

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-0.3% over one week, -10.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Soligenix (SNGX) seeks reverse stock split, higher share authorization to protect Nasdaq listing

Market Reaction

Balanced read

51/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -0.3% Price digesting
Trend fit Trend inactive -10.1% over four weeks
Fair value -91.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 30
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 35
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 10
Stock Titan 7
Market source 6
TradingKey 4
PR Newswire 4
The Globe and Mail 2
Quiver Quantitative 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 16
Analyst action 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 44
TradingView Direct company coverage

Soligenix, Inc. Financial Disclosures & SEC Filings

This page provides access to Soligenix, Inc.'s SEC filings and other corporate documents, including Forms 10-K, 10-Q, and 8-K. It details earnings reports and corporate presentations from 2022 through Q1 2026, highlighting key financial outcomes, clinical program updates, and str

Tone
Negative 29/100
Event
Earnings
Published
01 Jul 2026 11:10
Source
TradingView
The Globe and Mail Direct company coverage

Soligenix Expands At-the-Market Equity Offering Capacity

Soligenix Inc. has increased its At Market Issuance Sales Agreement with Rodman & Renshaw LLC by an additional $2.5 million, bringing the total amount available under the offering to over $8.7 million. This expansion allows Soligenix to continue raising capital through equity off

Tone
Negative 35/100
Event
Market update
Published
27 Jun 2026 20:40
Source
The Globe and Mail
Investing.com Direct company coverage

Form 424B5 Soligenix Inc For: 26 June

The article reports on the filing of Form 424B5 by Soligenix Inc. for June 26, as published by Investing.com. It contains a disclaimer about the high risks associated with trading financial instruments and cryptocurrencies, emphasizing that the data provided is not necessarily re

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 07:40
Source
Investing.com
TradingView Direct company coverage

Price to sales forward of Soligenix, Inc. – NASDAQ:SNGX

This article provides financial information for Soligenix, Inc. (NASDAQ: SNGX), specifically its forward price-to-sales ratio. It references data from TradingView, FactSet, and ICE Data Services. The content indicates the market was closed at the time of publication and that no t

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 07:11
Source
TradingView
Investing.com South Africa Direct company coverage

Form 424B5 Soligenix Inc For: 26 June By Investing.com

This article from Investing.com reports on a Form 424B5 filing by Soligenix Inc. The filing is dated for June 26. The article itself is very brief, mainly serving as a notification about the filing with financial market data and popular news links surrounding it.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 05:10
Source
Investing.com South Africa
TradingView Direct company coverage

Soligenix ups ATM offering by $2.5M under Rodman & Renshaw agreement

Soligenix (SNGX) has increased its at-the-market (ATM) issuance capacity by $2.5 million under its existing sales agreement with Rodman & Renshaw. This expansion follows previous sales totaling approximately $6.234 million against a prior capacity of $6.406 million. The company f

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:09
Source
TradingView
Stock Titan Direct company coverage

Soligenix (NASDAQ: SNGX) resets ATM capacity to $2.5M under S-3

Soligenix, Inc. (NASDAQ: SNGX) has amended its At-The-Market (ATM) sales agreement, resetting its capacity to $2.5 million under its Sales Agreement with Rodman & Renshaw LLC. This update, filed via a 424B5 prospectus supplement, replaces previously unsold amounts and is constrai

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Soligenix (NASDAQ: SNGX) adds $2.5M to at-the-market stock program

Soligenix, Inc. (NASDAQ: SNGX) has increased its at-the-market stock program capacity by $2.5 million through a new prospectus supplement. This allows the company to issue and sell more common stock through its existing sales agreement with Rodman & Renshaw LLC. The company had p

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Michael Liu, MJL Manager (SNGX) disclose 983,588 shares; related group holds material blocks

Michael Liu, MJL Manager LLC, and Capuchin Capital Fund LP have disclosed their beneficial ownership of SOLIGENIX, INC. (SNGX) shares via a Schedule 13G filing. Michael Liu reports beneficial ownership of 983,588 shares (5.7%), while MJL Manager LLC holds 893,588 shares (5.2%), a

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 19:40
Source
Stock Titan
TradingView Direct company coverage

Soligenix, Inc. Actuals & Estimates (NASDAQ:SNGX)

This article provides a detailed financial overview and analyst estimates for Soligenix, Inc. (NASDAQ:SNGX), covering its stock price performance, forecasts, historical highs and lows, volatility, market capitalization, earnings, and revenue. It also addresses frequently asked qu

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 18:40
Source
TradingView
TradingView Direct company coverage

SNGX Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for Soligenix, Inc. (SNGX) stock for 2027, based on analyst opinions. It includes financial data, past performance, and answers frequently asked questions about the company's stock, such as its current price, volatility, market ca

Tone
Neutral 50/100
Event
Analyst action
Published
25 Jun 2026 13:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Soligenix, Inc. – NASDAQ:SNGX

The article mentions the enterprise value to revenue forward for Soligenix, Inc. (NASDAQ: SNGX). It appears to be a financial data point from TradingView, which often provides various financial metrics for stocks. The content indicates this specific metric is related to Soligenix

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 13:11
Source
TradingView
TradingKey Direct company coverage

Soligenix Inc (SNGX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Soligenix Inc (SNGX) stock information, focusing on its dividend history and stock split events. It highlights that the company has not distributed dividends in the past five years and details several merger-related stock splits, primarily in

Tone
Neutral 50/100
Event
Deals and strategy
Published
21 Jun 2026 21:09
Source
TradingKey
TradingKey Direct company coverage

Soligenix Inc (SNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Soligenix Inc (SNGX), highlighting its current earnings forecast score of 8.00 and an average price target of $17.50, based on one analyst's "Buy" rating. It details the upside potential, recent EPS performance, and expected next-qua

Tone
Positive 80/100
Event
Earnings
Published
18 Jun 2026 13:10
Source
TradingKey
TradingKey Direct company coverage

Soligenix Inc (SNGX) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Soligenix Inc (SNGX), noting its current financial score is 6.59, ranking 238 out of 388 in the Biotechnology & Medical Research industry. It identifies the company's financial status as robust but its operating efficiency as low. Cru

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 00:39
Source
TradingKey
TradingKey Direct company coverage

Soligenix Inc (SNGX) Institutional Confidence

This article provides an overview of the institutional confidence in Soligenix Inc (SNGX), noting its stock price, market cap, and various financial scores from TradingKey. It details institutional shareholding and shareholder activity, highlighting changes in shares held by seve

Tone
Negative 39/100
Event
Market update
Published
17 Jun 2026 00:10
Source
TradingKey
Finviz Direct company coverage

SNGX - Soligenix Inc Stock Price and Quote

This page provides a detailed financial overview and news compilation for Soligenix Inc. (SNGX), a late-stage biopharmaceutical company focusing on rare diseases. It includes stock performance data, key financial metrics, recent analyst ratings, and a chronological list of news e

Tone
Neutral 50/100
Event
Analyst action
Published
16 Jun 2026 11:11
Source
Finviz
TradingView Direct company coverage

Soligenix's Richard C. Straube ceases Consulting CMO role; duties moved to Christopher Pullion

Richard C. Straube has ended his role as Consulting Chief Medical Officer for Soligenix on June 11, 2026. His responsibilities have been transferred to Medical Director Christopher Pullion. This change occurred due to the company's decision to terminate its HyBryte™ development p

Tone
Negative 38/100
Event
Market update
Published
12 Jun 2026 20:09
Source
TradingView
TradingView Direct company coverage

Soligenix Received Notice of Noncompliance

Soligenix (SNGX) received a notice from Nasdaq on June 10, 2026, indicating noncompliance with the minimum bid price requirement for having its stock trade below $1.00 for 30 consecutive business days. The company has 180 days, until December 7, 2026, to regain compliance, with a

Tone
Negative 28/100
Event
Market update
Published
12 Jun 2026 20:09
Source
TradingView
Stock Titan Direct company coverage

Soligenix (NASDAQ: SNGX) faces Nasdaq bid-price risk and ends HyBryte program

Soligenix (NASDAQ: SNGX) announced the termination of its HyBryte™ development program following an interim analysis of its Phase 3 trial that recommended stopping due to futility, resulting in an estimated $70,000 in wind-down costs. Concurrently, the company received a Nasdaq w

Tone
Negative 8/100
Event
Market update
Published
12 Jun 2026 20:09
Source
Stock Titan
PR Newswire Direct company coverage

Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine

Soligenix, Inc. is applying for vaccine development funding from the Coalition for Epidemic Preparedness Innovations (CEPI) for a Bundibugyo virus (BDBV) vaccine. The company, in collaboration with Dr. Axel Lehrer of the University of Hawaiʻi at Mānoa, has developed thermostable

Tone
Positive 67/100
Event
Market update
Published
08 Jun 2026 11:39
Source
PR Newswire
The Globe and Mail Direct company coverage

Soligenix Expands At-The-Market Equity Financing Capacity

Soligenix, a biopharmaceutical company, has increased its At-The-Market (ATM) equity financing capacity by an additional $2,956,000, following previous sales of approximately $3,445,000 under the same program. This move allows Soligenix greater financial flexibility for its opera

Tone
Negative 34/100
Event
Market update
Published
31 May 2026 07:40
Source
The Globe and Mail
Minichart Direct company coverage

Soligenix, Inc. Files SEC Form 8-K for May 28, 2026 – Company Information and Legal Exhibits

Soligenix, Inc. filed an 8-K with the SEC announcing an increase in its At Market Issuance Sales Agreement with Rodman & Renshaw LLC by $2,956,000, bringing the total to $6,406,000. This move, approved by the Board of Directors, aims to raise capital but also introduces potential

Tone
Negative 36/100
Event
Market update
Published
29 May 2026 14:39
Source
Minichart
Stock Titan Direct company coverage

Soligenix (NASDAQ: SNGX) raises at-the-market stock capacity by $2.96M

Soligenix (NASDAQ: SNGX) has increased its at-the-market stock offering capacity by an additional $2.96 million through a prospectus supplement. This expands an existing sales agreement with Rodman & Renshaw LLC, under which the company had previously sold approximately $3.445 mi

Tone
Neutral 50/100
Event
Market update
Published
28 May 2026 21:38
Source
Stock Titan
Stock Titan Direct company coverage

Soligenix (NASDAQ: SNGX) raises ATM ceiling to $2.96M under Sales Agreement

Soligenix, Inc. has updated its at-the-market (ATM) offering capacity to $2.96 million for common stock under a Sales Agreement with Rodman & Renshaw LLC. This adjustment is based on a public float of $24.51 million and aligns with General Instruction I.B.6 of Form S-3. The compa

Tone
Neutral 50/100
Event
Market update
Published
28 May 2026 21:38
Source
Stock Titan